^
    8d
    ASCLEPIuS: A Multi-Center Trial of Androgen Suppression With Abiraterone Acetate, Leuprolide, PARP Inhibition and Stereotactic Body Radiotherapy in Prostate Cancer (clinicaltrials.gov)
    P1/2, N=102, Active, not recruiting, University of Michigan Rogel Cancer Center | Trial completion date: May 2027 --> May 2029 | Trial primary completion date: Nov 2026 --> May 2027
    Trial completion date • Trial primary completion date
    |
    DRD (DNA Repair Deficiency)
    |
    DDR
    |
    Zejula (niraparib) • abiraterone acetate • leuprolide acetate for depot suspension
    12d
    A Comparative Dose-finding Study of RS-113 in Patients With Metastatic Castration-resistant Prostate Cancer (clinicaltrials.gov)
    P2, N=120, Active, not recruiting, R-Pharm International, LLC
    New P2 trial
    |
    abiraterone acetate • triptorelin • goserelin acetate
    12d
    Clinical Study on the Preservation of Ovarian Function Following Hematopoietic Stem Cell Transplantation in Patients With Malignant Hematologic Diseases Using Goserelin (clinicaltrials.gov)
    P=N/A, N=64, Not yet recruiting, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
    New trial
    |
    melphalan • goserelin acetate
    12d
    Clinical Study on the Preservation of Ovarian Function in Patients With Aplastic Anemia Following Allogeneic Hematopoietic Stem Cell Transplantation Using Goserelin (clinicaltrials.gov)
    P=N/A, N=132, Not yet recruiting, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
    New trial
    |
    goserelin acetate
    13d
    Clinical Study on the Preservation of Ovarian Function Following Autologous Hematopoietic Stem Cell Transplantation Using Goserelin (clinicaltrials.gov)
    P=N/A, N=64, Not yet recruiting, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
    New trial
    |
    melphalan • goserelin acetate
    16d
    Comparison of the Therapeutic Effects of Vaginal Repair With Leuprorelin and Vaginal Repair in the Treatment of Cesarean Section Scar Defect (clinicaltrials.gov)
    P=N/A, N=94, Recruiting, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine | Trial completion date: Apr 2026 --> Dec 2027 | Trial primary completion date: Apr 2025 --> Apr 2027
    Trial completion date • Trial primary completion date
    |
    leuprolide acetate for depot suspension
    17d
    Multi-center, randomized trial for evaluation of the efficacy of GnRHa in reducing the recurrence rate of multiple uterine fibroids after myomectomy (ChiCTR-IPR-17012992)
    P4, N=640, Completed, Tongji Medical College Huazhong University of Science and Technology; Tongji Medical College Huazhong University of Science and Technology | Recruiting --> Completed
    Trial completion
    18d
    Prostate cancer presenting as brain metastasis with concurrent elevation of carcinoembryonic antigen and carbohydrate antigen 19-9 levels: illustrative case. (PubMed, J Neurosurg Case Lessons)
    Brain metastases from prostate cancer with elevated CEA and CA19-9 are rare. Although these markers often indicate a poor prognosis, this patient achieved a favorable outcome with multimodal treatment. https://thejns.org/doi/10.3171/CASE25735.
    Journal
    |
    CEACAM5 (CEA Cell Adhesion Molecule 5) • CA 19-9 (Cancer antigen 19-9) • NKX3-1 (NK3 homeobox 1)
    |
    docetaxel • Nubeqa (darolutamide) • leuprolide acetate for depot suspension
    24d
    NIRO: Norethindrone Impact on Receptiva Outcomes (clinicaltrials.gov)
    P=N/A, N=99, Completed, Inception Fertility Research Institute, LLC | Active, not recruiting --> Completed | N=700 --> 99 | Trial completion date: Jul 2026 --> Dec 2025
    Trial completion • Enrollment change • Trial completion date
    |
    BCL6 (B-cell CLL/lymphoma 6)
    |
    leuprolide acetate for depot suspension
    1m
    ADOPT: Androgen Deprivation Therapy for Oligo-recurrent Prostate Cancer in Addition to radioTherapy (clinicaltrials.gov)
    P3, N=280, Active, not recruiting, University Medical Center Groningen | Not yet recruiting --> Active, not recruiting
    Enrollment closed
    |
    Eligard (leuprolide acetate)
    1m
    Effect of Education on Treatment Decision Making for Patients With Prostate Cancer on Chronic Hormone Treatments (clinicaltrials.gov)
    P=N/A, N=101, Completed, University of Chicago | Trial primary completion date: Dec 2027 --> Apr 2025 | Recruiting --> Completed | Trial completion date: Dec 2027 --> Apr 2025
    Trial completion • Trial completion date • Trial primary completion date
    2ms
    Gonadotropin-releasing Hormone Agonist (GnRHa) in Ovarian Preservation in SLE Subjects Receiving Cyclophosphamide as Determined by Questionnaires (clinicaltrials.gov)
    P=N/A, N=100, Recruiting, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | Trial completion date: May 2026 --> May 2027 | Trial primary completion date: May 2026 --> May 2027
    Trial completion date • Trial primary completion date
    |
    cyclophosphamide